Department Of Medicine 4
151. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
152. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
153. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
154. Global, regional, and national burden of household air pollution, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
155. Peptide-based drug delivery systems
156. Stimuli-responsive polymers for transdermal, transmucosal and ocular drug delivery
157. Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis
158. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
159. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
160. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
161. Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023
162. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
163. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
164. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
165. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
166. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
167. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
168. Predictive Role of Progesterone Levels for IVF Outcome in Different Phases of Controlled Ovarian Stimulation for Patients With and Without Endometriosis: Expert View
169. Predictive Value of Basal Serum Progesterone for Successful IVF in Endometriosis Patients: The Need for a Personalized Approach
170. Case Report: A Rare Case of a Combination of Omphalocele With Umbilical Teratoma
171. The Technique of Mobilization of the Colon for Pull-Through Procedure in Hirschsprung’s Disease
172. The Incidence, Mortality, and Survival Trends of Pancreatic Cancer in Kazakhstan: Data from the National Electronic Registry of Oncological Patients (2014–2023)
173. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
174. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
175. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
176. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
177. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
178. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
179. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
180. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
181. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
182. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
183. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
184. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
185. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
186. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
187. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
188. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
189. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
190. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
191. Perceived built environment characteristics associated with walking and cycling across 355 communities in 21 countries
192. Perceived built environment characteristics associated with walking and cycling across 355 communities in 21 countries
193. Hemadsorption with CytoSorb in Infants with Sepsis: Non-Systematic Review of Cases
194. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
195. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
196. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
197. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
198. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
199. Methodology for the Development of the Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI 2024–2025 Guidelines: From Evidence-to-Decision Frameworks to Digitalised Shared Decision-Making Algorithms
200. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force Report
1 2 3 4 5 6 24